Furthermore, a recent randomized controlled trial has shown elevated levels of vWF in induced DM/HC (diabetes mellitus/hypercholesterolemia) swine, which developed atherosclerosis, suggesting that vWF might be a potential marker of endothelial dysfunction in people with metabolic syndrome [135,136]. The gene discussed is VWF; the disease is atherosclerosis.